Clinical trials: Pigmented Skin
Hermansky Pudlak Syndrome
A Longitudinal Study of Hermansky-Pudlak Syndrome Pulmonary Fibrosis
Hermansky-Pudlak Syndrome (HPS) is a rare genetic disease that is associated with oculocutaneous albinism, bleeding, granulomatous colitis, and pulmonary fibrosis in some subtypes, including HPS-1, HPS-2, and HPS-4.
- Trial name
- NCT02368340
- Testing
- Pulmonary function test, Chest CT, Sample collection
- Where
- 5 sites in United States
- Volunteers
- 55 people
- Sponsor
- Vanderbilt University
Vitiligo, Tacrolimus
Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo
The study will evaluate the effectiveness of Tacrolimus 0.03% ointment monotherapy in patients with vitiligo. Patients will be treated for 6 months and followed for 3 months after treatment. All types of vitiligo will be included.
- Trial name
- NCT03358082
- Testing
- Tacrolimus 0.03% Ointment, Hydrocortisone Acetate 1% Ointment
- Where
- Egypt
- Volunteers
- 100 people
- Sponsor
- Sohag University